Xarelto Lawsuit Filed In New York Alleges Drug Caused Internal Bleeding Injuries

A lawsuit has been filed in the New York District Court alleging that the manufacturers of Xarelto did not perform sufficient safety testing on the anticoagulant drug and failed to warn about significant risks. This is one of many Xarelto lawsuits filed after recent studies linked its use severe side effects including uncontrollable internal bleeding.

A Texas woman has filed a lawsuit in New York federal court against the manufacturers of Xarelto – a popular prescription blood thinner – claiming that the drug caused her to suffer serious injuries from internal bleeding.

The complaint alleges that drug companies Bayer AG and Janssen Pharmaceuticals did not perform sufficient safety testing on their anticoagulant drug and failed to warn the public about signficant risks, which they had known about.

This lawsuit is one of many which have been filed recently against Janssen and Bayer AG after recent studies linked their blockbuster drug Xarelto to severe internal bleeding which can lead to serious injury and death.

Xarelto: A New Type of Prescription Blood Thinner

Xarelto is a new class of prescription blood thinner (or anticoagulant) which is prescribed to reduce the risks of blood clotting in patients with various medical conditions including Deep Vein Thrombosis (DVT), Atrial Fibrillation (A-fib) and other related conditions.

Since its initial FDA approval in 2011, Xarelto has quickly become the leading blood thinner in its class with more than 11 million prescriptions in the U.S. and continued sales growth.

However, the drug has come under serious scrutiny recently after studies showed a link to concerning side effects including uncontrollable internal bleeding.

Unlike traditional blood thinners, Xarelto does not have an antidote, or reversing agent to stop the drug’s blood-thinning effects.

As a result, many Xarelto users have suffered from internal bleeds which ended up causing serious injury or death.

Now, lawsuits are being filed throughout the country by individuals and families who may have been harmed.

Details of The New York Lawsuit

In this specific case, the plaintiff was prescribed Xarelto by her doctor to prevent blood clots caused by Atrial Fibrillation.

The complaint, filed under docket number 1:14-CV-04524 in the Eastern District of New York, states that the plaintiff took Xarelto for 5 months and then suffered a life-threatening internal bleed which resulted in serious injury.

The claim alleges that the manufacturers’ failure to warn about Xarelto’s risks and insufficent safety testing lead the plaintiff to suffer serious injuries.

The complaint did not mention the nature the injuries suffered, however it did state that the plaintiff incurred permanent injuries which will require future care.

Families Contacting Sheller P.C. About Xarelto Lawsuits

In response to pending litigation, Xarelto lawyer Marc Goldich of BloodThinnerHelp.com said, “Many individuals and families are just learning that Xarelto may have caused a serious injury or death of a loved one. We understand that these are difficult times and are doing everything we can to assist these families in pursuing justice.”

For media contacts and questions regarding the Xarelto litigation, please call 866-425-8902.

Contact Info:
Name: Marc Goldich
Email: mgoldich@sheller.com
Phone: 866-425-8902
Organization: Blood Thinner Help

Source URL: http://www.prreach.com/pr/17943

Release ID: 83870